Table 1.
Age, M (SD) | 60.1 (13.1) |
Female, n (%) | 96 (52.7) |
Race/Ethnicity, n (%) | |
White | 132 (72.5) |
Black | 8 (4.4) |
Hispanic/Latino | 21 (11.5) |
Asian/Pacific Islander | 13 (7.1) |
Other | 8 (4.4) |
Cancer site, n (%) | |
Genitourinary | 40 (22.0) |
Breast | 39 (21.4) |
Gastrointestinal | 34 (18.7) |
Hematologic | 17 (9.4) |
Respiratory | 15 (8.2) |
Lymphoma | 9 (5.0) |
Neurologic | 9 (5.0) |
Head and Neck | 7 (3.8) |
Musculoskeletal | 5 (2.7) |
Neuroendocrine | 4 (2.2) |
Other | 3 (1.6) |
DCCI, M (SD) | 1.7 (2.2) |
Metastatic disease, n (%) | 59 (32.4) |
Annual mental health visits, M (SD) | 3.6 (7.9) |
Note. DCCI = Deyo-Charlson Comorbidity Index.